Navigation Links
Thermogenesis Announces New Initiative to Address Veterinary Regenerative Medicine
Date:2/6/2008

Executive Officer of ThermoGenesis.

"We have the potential to create a new paradigm for the treatment of injured performance horses using our unique approach of capturing stem cells when the horse is born up through the first year of life. This represents a potentially sizeable market opportunity for the Company in which we believe we can achieve a meaningful competitive advantage quickly. Equine stem cells are being used successfully to treat a number of injuries today, with the potential for significant and rapid growth given the early clinical efficacy of these treatments and relatively low regulatory hurdles in the veterinary market," he added.

"The collaborative support and assistance we will be receiving from Vantus should allow our scientists to move forward rapidly in the development of new and unique veterinary stem cell applications. We expect that their experience in the processing and bioarchival storage of stem cells, combined with the expertise of our research and clinical personnel, will provide compelling synergy for scientific discovery," said Dr. Gregory Ferraro, of the UC Davis Center for Equine Health.

Osgood noted, "In addition, the experience we gain in the veterinary stem cell market and the products and services that will come from research and innovations in harvesting, processing, and therapeutic treatments, will directly translate to treatment of human orthopedic injury and disease and speed our entry into this evolving market."

"Finally, we believe our wound healing technologies will have direct application in the veterinary market, which we expect will add additional revenues to the Company," he added.

To learn more about Vantus please log onto http://www.vantuslabs.com.

About ThermoGenesis Corp.

ThermoGenesis Corp. (http://www.thermogenesis.com) is a leading supplier of innovativ
'/>"/>

SOURCE ThermoGenesis Corp.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. ThermoGenesis Corp. Reports First Quarter 2008 Results
2. ThermoGenesis Announces 510(k) Clearance for AutoXpress(TM) Cord Blood Processing System
3. Zipfizz(R) Announces Expanded Distribution
4. Mangrove Announces Health Savings Account (HSA) and Health Reimbursement Account (HRA) Product Launches
5. Senetek PLC Announces Launch of New Website
6. Nile Therapeutics Announces Dosing of First Heart Failure Patient in Phase Ib Study of CD-NP
7. Galaxy Nutritional Foods Announces Third Quarter FY2008 Earnings Conference Call for Friday, February 8, 2008
8. Sentillion Announces Strong Q4 Performance; Signs 10 New Customers; Sells 95,800 Licenses
9. Cyberonics Announces Conference Call to Discuss FY08 Q3 Financial Results
10. The Female Health Company Announces FDA Acceptance for Review of Its FC2 Premarket Approval Application
11. Thermage, Inc. Announces Fourth Quarter 2007 Results Release Date and Conference Call
Post Your Comments:
*Name:
*Comment:
*Email: